Search research articles
Contact Us
Filters
Showing results (121-130 of 207) with videos related to
Page
of 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
Joseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 9, 2023
<sup>68</sup>Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines
Ida Sonni, Alan Dal Pra, Dylan P O'Connell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 18, 2024
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
Andrei Gafita, Loic Djaileb, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2018
Detection Threshold and Reproducibility of <sup>68</sup>Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer
Katharina Lückerath, Andreea D Stuparu, Liu Wei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 2, 2023
Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials
Clayton P Smith, Michael Xiang, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
SNMMI Consensus Statement on Patient Selection and Appropriate Use of
Thomas A Hope, Emmanuel S Antonarakis, Lisa Bodei, et al.
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [<sup>177</sup>Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Loïc Djaileb, Andrea Farolfi, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 25, 2024
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)
John Nikitas, Ethan Lam, Kiara Adame Booker, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 207) with videos related to
Sort By:
Page
of 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
Joseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 9, 2023
<sup>68</sup>Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines
Ida Sonni, Alan Dal Pra, Dylan P O'Connell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 18, 2024
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
Andrei Gafita, Loic Djaileb, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2018
Detection Threshold and Reproducibility of <sup>68</sup>Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer
Katharina Lückerath, Andreea D Stuparu, Liu Wei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 2, 2023
Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials
Clayton P Smith, Michael Xiang, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
SNMMI Consensus Statement on Patient Selection and Appropriate Use of
Thomas A Hope, Emmanuel S Antonarakis, Lisa Bodei, et al.
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [<sup>177</sup>Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Loïc Djaileb, Andrea Farolfi, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 25, 2024
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)
John Nikitas, Ethan Lam, Kiara Adame Booker, et al.
Page
of 21